• Moves to delay second dose of Pfizer vaccine not supported by test data

    13 days ago - By Natural News

    BioNTech, the German biotech group that worked with Pfizer to develop the first Wuhan coronavirus vaccine together to receive approval, warned that there was “no data” to support moves to delay the second dose of the vaccine. The delays had initially been proposed by the U.K. government as a means to get the first dose to...
    Read more ...